Subtopic Deep Dive
Neuroferritinopathy and Brain Iron Accumulation
Research Guide
What is Neuroferritinopathy and Brain Iron Accumulation?
Neuroferritinopathy is a rare autosomal dominant neurodegenerative disorder caused by mutations in the FTL1 gene encoding the ferritin light chain, leading to iron dysregulation, brain iron accumulation, and movement disorders with characteristic basal ganglia cystic degeneration.
FTL1 mutations impair ferritin function, resulting in iron toxicity and neurodegeneration primarily in the basal ganglia (Curtis et al., 2001, 539 citations). Neuroimaging shows iron accumulation and cystic changes correlating with clinical symptoms like dystonia and chorea. This condition falls under neurodegeneration with brain iron accumulation (NBIA) disorders (Gregory et al., 2008, 359 citations). Over 20 papers detail genetic, clinical, and iron metabolism aspects.
Why It Matters
Neuroferritinopathy serves as a genetic model for brain iron dysregulation mechanisms implicated in Parkinson's disease, where excess iron promotes oxidative stress and neuronal loss (Jellinger et al., 1990, 446 citations; Gerlach et al., 1994, 706 citations). Iron chelation studies in MPTP models demonstrate neuroprotection, suggesting therapeutic strategies applicable to NBIA and related disorders (Kaur et al., 2003, 616 citations). Understanding ferritin dysfunction aids development of chelators and antioxidants for iron-overload neurodegenerative conditions (Hare et al., 2013, 428 citations).
Key Research Challenges
Iron Toxicity Mechanisms
Excess labile iron generates oxidative stress via Fenton reactions, damaging oligodendrocytes and myelin (Connor and Menzies, 1996, 721 citations). Linking ferritin mutations to specific neuronal vulnerability remains unclear. Therapies must balance iron chelation without depleting essential stores (Kaur et al., 2003).
Genetic-Clinical Correlation
FTL1 mutations show variable penetrance and phenotypes within families (Curtis et al., 2001). Correlating genotypes with neuroimaging patterns like basal ganglia cysts needs larger cohorts (Gregory et al., 2008). Phenocopies complicate diagnosis.
Therapeutic Targeting
Iron chelators prevent toxicity in models but lack human trials for neuroferritinopathy (Kaur et al., 2003). Balancing brain iron homeostasis without disrupting myelination poses risks (Connor and Menzies, 1996). Biomarker development for early intervention is absent.
Essential Papers
Relationship of iron to oligondendrocytes and myelination
James R. Connor, Sharon Menzies · 1996 · Glia · 721 citations
Oligodendrocytes are the predominant iron-containing cells in the brain. Iron-containing oligodendrocytes are found near neuronal cell bodies, along blood vessels, and are particularly abundant wit...
Altered Brain Metabolism of Iron as a Cause of Neurodegenerative Diseases?
M. Gerlach, Dorit Ben‐Shachar, Peter Riederer et al. · 1994 · Journal of Neurochemistry · 706 citations
Abstract: Iron is the most abundant metal in the human body (Pollitt and Leibel, 1982; Youdim, 1988), and the brain, like the liver, contains a substantially higher concentration of iron than of an...
Oxidative stress and nitration in neurodegeneration: Cause, effect, or association?
Harry Ischiropoulos, Joseph S. Beckman · 2003 · Journal of Clinical Investigation · 654 citations
Nonstandard abbreviations used: amyotrophic lateral sclerosis (ALS); manganese superoxide dismutase (Mn-SOD); Cu/Zn superoxide dismutase (Cu/Zn-SOD); hypochlorous acid (HOCl); nitric oxide synthase...
Genetic or Pharmacological Iron Chelation Prevents MPTP-Induced Neurotoxicity In Vivo
Deepinder Kaur, Ferda Yantiri, Subramanian Rajagopalan et al. · 2003 · Neuron · 616 citations
Basic mechanisms of neurodegeneration: a critical update
K. A. Jellinger · 2010 · Journal of Cellular and Molecular Medicine · 569 citations
Abstract Introduction Protein aggregation Oxidative injury Impaired bioenergetics and mitochondrial dysfunction Fragmentation of neuronal Golgi apparatus Disruption of cellular/axonal transport Dys...
Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease
Andrew R.J. Curtis, Constanze Fey, Christopher M. Morris et al. · 2001 · Nature Genetics · 539 citations
The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging
Luigi Zecca, Antonella Stroppolo, Alberto Gatti et al. · 2004 · Proceedings of the National Academy of Sciences · 495 citations
In this study, a comparative analysis of metal-related neuronal vulnerability was performed in two brainstem nuclei, the locus coeruleus (LC) and substantia nigra (SN), known targets of the etiolog...
Reading Guide
Foundational Papers
Start with Curtis et al. (2001) for FTL1 mutation discovery in neuroferritinopathy; Connor and Menzies (1996) for iron-oligodendrocyte role; Gerlach et al. (1994) for iron metabolism in neurodegeneration.
Recent Advances
Gregory et al. (2008) for NBIA classification including neuroferritinopathy; Hare et al. (2013) for iron homeostasis in brain disease; Jellinger (2010) for updated neurodegeneration mechanisms.
Core Methods
Genetic: FTL1 sequencing (Curtis 2001); Imaging: MRI T2* for iron/cysts (Gregory 2008); Histology: Perl's stain for iron, ferritin IHC (Connor 1996); Models: MPTP chelation (Kaur 2003).
How PapersFlow Helps You Research Neuroferritinopathy and Brain Iron Accumulation
Discover & Search
Research Agent uses searchPapers and citationGraph to map FTL1 mutation literature from Curtis et al. (2001), revealing 539 citing papers on NBIA; exaSearch uncovers related iron dysregulation studies like Connor and Menzies (1996); findSimilarPapers expands to Hare et al. (2013) for metabolism links.
Analyze & Verify
Analysis Agent applies readPaperContent to extract iron quantification methods from Jellinger et al. (1990), then runPythonAnalysis with pandas to meta-analyze iron levels across Parkinson's and NBIA datasets; verifyResponse via CoVe cross-checks claims against Gerlach et al. (1994); GRADE grading scores evidence strength for chelation efficacy from Kaur et al. (2003).
Synthesize & Write
Synthesis Agent detects gaps in FTL1 therapy trials via contradiction flagging across Curtis et al. (2001) and Gregory et al. (2008); Writing Agent uses latexEditText and latexSyncCitations to draft reviews with synced refs, latexCompile for PDF output, exportMermaid for iron metabolism pathway diagrams.
Use Cases
"Analyze iron accumulation data from NBIA papers using Python."
Research Agent → searchPapers('neuroferritinopathy iron levels') → Analysis Agent → readPaperContent(Jellinger 1990) + runPythonAnalysis(pandas plot of ferritin vs iron metrics) → matplotlib graph of brain iron correlations.
"Write LaTeX review on FTL1 mutations and basal ganglia pathology."
Synthesis Agent → gap detection(Curtis 2001 + Gregory 2008) → Writing Agent → latexEditText(structured sections) → latexSyncCitations(all refs) → latexCompile → PDF with cystic degeneration figure.
"Find code for ferritin iron modeling from related papers."
Research Agent → paperExtractUrls(iron metabolism papers) → paperFindGithubRepo → Code Discovery → githubRepoInspect(simulations from Hare 2013 citations) → runPythonAnalysis(adapt model to FTL1 data).
Automated Workflows
Deep Research workflow conducts systematic review of 50+ NBIA papers: searchPapers → citationGraph(Curtis 2001) → structured report on iron genetics. DeepScan applies 7-step analysis with CoVe checkpoints to verify chelation data from Kaur et al. (2003). Theorizer generates hypotheses linking ferritin to Parkinson's iron from Connor and Menzies (1996) + Gerlach et al. (1994).
Frequently Asked Questions
What defines neuroferritinopathy?
Neuroferritinopathy arises from FTL1 gene mutations causing ferritin light chain dysfunction, iron dysregulation, and basal ganglia degeneration with movement disorders (Curtis et al., 2001).
What are key methods in brain iron studies?
Methods include genetic sequencing of FTL1, MRI for iron detection and cysts, and histochemistry for ferritin/iron in oligodendrocytes (Curtis et al., 2001; Connor and Menzies, 1996).
What are seminal papers?
Curtis et al. (2001, Nature Genetics, 539 citations) identified FTL1 mutations; Gregory et al. (2008) delineated NBIA genetics; Connor and Menzies (1996, 721 citations) linked iron to myelination.
What open problems exist?
Challenges include variable FTL1 phenotype-genotype links, lack of disease-modifying therapies beyond chelators, and biomarkers for preclinical iron accumulation (Gregory et al., 2008; Kaur et al., 2003).
Research Neurological diseases and metabolism with AI
PapersFlow provides specialized AI tools for Neuroscience researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Systematic Review
AI-powered evidence synthesis with documented search strategies
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
See how researchers in Life Sciences use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Neuroferritinopathy and Brain Iron Accumulation with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Neuroscience researchers